Qida raises €37 million to continue improving the quality of life of the senior segment at home - Asabys Partners

Compatibilità
Salva(0)
Condividi

READ THIS NEWS IN SPANISH

  • The round is led by Quadrille Capital and co-led by Asabys Partners and COFIDES (Social Impact Fund). ICF and Endeavor Catalyst also join the round
  • Existing investors also participate in this operation, including Kibo Ventures, Creas, Ship2B Ventures, and individual investors with expertise in the healthcare, social, and insurance sectors
  • The investment will enable Qida to boost growth, technological innovation, and the attraction of top talent, with the goal of reaching more than 100,000 people served and quadrupling sales within three years
  • The company, certified as a B Corp, is a national leader in the social impact economy and will continue maximizing the “Triple M”: More people, living More time, with More quality of life at home
  • As of today, Qida will have raised the largest direct social impact investment round ever closed in Spain

Qida, the leading provider of home-based products and services for senior well-being, has announced the closing of a €37 million funding round led by Quadrille Capital, and co-led by Asabys (Sabadell Asabys II)  and COFIDES, manager of the Fondo Impacto Social (FIS). The round also welcomes participation from the U.S.-based Endeavor Catalyst and the Institut Català de Finances (ICF), further reinforcing their commitment to innovative projects with a clear social impact Existing investors Kibo Ventures, Creas, and Ship2B have decided to reinvest, reaffirming their confidence in the company’s trajectory and business model. The capital raised will be allocated to three strategic areas: growth, technology and team strengthening As of today, Qida will have raised the largest  direct social impact investment round ever closed in Spain.

In terms of growth, Qida plans to expand both organically and inorganically, consolidating its presence in Spain’s main cities. The goal is to continue maximizing the quality of life of the senior population, reaching over 100,000 people served, while further promoting public-private collaboration and social impact.

On the technological front, the company will invest in customer-oriented product development, enhancing artificial intelligence and digital tools to enable a preventive, proactive, and integrated care model bridging the health and social spheres.

Team expansion is also a priority, with key additions such as Daniel Alonso, former CPO at Glovo, whose product and management experience will be instrumental in supporting Qida’s expansion. “I’m extremely proud to count on the support of leading public and private funds, as well as all our long-term partners who share the same mission: maximizing the quality of life of the senior segment. This investment allows us not only to grow and strengthen our leadership, but also to further expand our social impact” said Oriol Fuertes, CEO of Qida.

Alejandra Durán Gil, Partner and CIO at Quadrille Capital, added: “We have full confidence in Qida’s business model and growth potential, backed by solid financial discipline and efficient capital management. The company combines technological innovation with a people-centered approach, positioning it as a clear leader in the sector.”

Guillem Masferrer, Partner at Asabys Partners, stated:“Our investment in Qida reinforces our commitment to companies that generate real impact within the healthcare system and in people’s lives, promoting a high-quality, preventive, and home-based care model with sustainable growth potential.”

Finally, Raúl Sánchez, Director of the Fondo de Impacto Social (FIS) managed by COFIDES, noted: “Qida is one of the leading social impact companies in Spain and a clear example of how profitability and positive social outcomes can go hand in hand. We believe the company will play a key role in transforming and improving the healthcare and social care systems in Spain, and we’re delighted to support them in this new phase of growth.”

With this operation, Qida moves forward in its goal to quadruple sales within three years and to consolidate a care model that combines technology, prevention, and human companionship—while maximizing its social impact.

The company thus strengthens its position as Spain’s leading innovator in social and healthcare services, reaffirming its commitment to making home care a more dignified, efficient, and human experience.

About Qida

Qida is Spain’s leading company in home-based care and companionship for the senior population. Its mission is to help more people live longer and better at home through an innovative model that integrates care, prevention, technology, and coordinated health and social services.

Since its creation, it has supported more than 20,000 families and collaborates with public administrations and private entities to build a more efficient, personalized, and human care system.

As a B Corp and social impact company, Qida promotes a new paradigm of person-centered care: providing high-quality public and private care services, developing prevention programs, applying advanced technology for home care (SAD) management and integrated coordination, and acting as an integrator of in-home solutions. Its clear purpose: to transform care in Spain.

www.qida.es

About Quadrille Capital

Quadrille Capital is a global investment platform focused on high-growth technology. Over the past 25 years, Quadrille has backed successful companies such as Jobandtalent, Homa, and Exoticca in Europe, as well as ezCater, Hinge Health, and Sanas in the U.S. The firm also invests through complementary Secondary and Primary strategies, managing €1.8 billion in assets with a team of 50 professionals across offices in Paris, New York, and San Francisco.

About Asabys Partners

Asabys Partners is a Barcelona-based venture capital firm focused on innovation in healthcare and life sciences, including biopharma, medical technology, and digital health. Founded in 2018 by Josep Ll. Sanfeliu and Clara Campàs, the firm is backed by Alantra and supported by Banc Sabadell as anchor investor. Asabys aims to support highly innovative and transformative technologies that address unmet medical needs. The firm manages over €400 million in assets and has 22 portfolio companies. Asabys positions itself not only as an investor but as an active and collaborative partner to its portfolio companies, with the goal of translating disruptive science into meaningful outcomes for patients. The investment in the company comes from its vehicles Sabadell Asabys Health Innovation Investments II, FCR, and Sabadell Asabys Health Innovation Investments 2B, SCR SA.

 www.asabys.com

About COFIDES

COFIDES is a state-owned company that manages financial instruments on behalf of the Spanish Government, as well as its own and third-party resources, with various objectives: promoting the internationalization of the Spanish economy, attracting foreign investment to strategic sectors in Spain, fostering the impact economy, and contributing to development in the countries where it invests.

Alongside the Spanish State as the majority shareholder, COFIDES’ shareholders include Banco Santander, BBVA, Banco Sabadell, and CAF – Development Bank of Latin America 

About the Social Impact Fund (FIS)

The FIS is a fund created by the Spanish Government as part of the Recovery, Transformation and Resilience Plan (PRTR) and financed by NextGenerationEU. Under the Ministry of Inclusion, Social Security and Migration, it is a public financial instrument designed to strengthen Spain’s impact investment ecosystem by supporting companies and entities that generate measurable positive social and/or environmental impact.

About Endeavor Catalyst

Endeavor is the Global Trust Network of, by, and for entrepreneurs. The organization selects, supports, and invests in high-potential founders, offering them a platform to mentor, empower, and invest in the next generation through the Endeavor Multiplier Effect™.

To sustain its long-term operations in alignment with its mission, Endeavor created Endeavor Catalyst—a rules-based co-investment fund designed to invest in the same high-growth entrepreneurs Endeavor supports. With over $540 million in assets under management and more than 380 investments across 35 countries, Endeavor Catalyst has become one of the leading early-stage investors in startups that have grown into billion-dollar companies (unicorns) outside the U.S. and China.
 https://endeavor.org/catalyst/

About ICF

The Institut Català de Finances (ICF) has been Catalonia’s public development bank for 40 years, financing more than 37,000 clients with over €16 billion in total funding. Its main mission is to promote business and institutional financing to foster growth, innovation, and sustainability within the Catalan economy.

The ICF complements the private financial sector by offering a wide range of financing solutions focused on loans, guarantees, and venture capital investment. Since 2014, it has been a member of the European Association of Public Banks (EAPB), which brings together most of Europe’s public promotional banks and financial institutions.
 https://www.icf.cat

PortfolioQida raises €37 million to continue improving the quality of life of the senior segment at home

November 4, 2025

Qida raises €37 million to continue improving the quality of life of the senior segment at home

READ THIS NEWS IN SPANISH The round is led by Quadrille Capital and co-led by Asabys Partners and COFIDES (Social Impact Fund). ICF and Endeavor Catalyst also join the round…

PortfolioOna Therapeutics, a portfolio company of Asabys Partners and Alta Life Sciences, appoints Dr. Antoine Yver as Chair of the Board to accelerate its ADC programs towards clinical development

October 14, 2025

Ona Therapeutics, a portfolio company of Asabys Partners and Alta Life Sciences, appoints Dr. Antoine Yver as Chair of the Board to accelerate its ADC programs towards clinical development

• Brings over 35 years of oncology drug development experience, including senior executive leadership roles at AstraZeneca and Daiichi Sankyo • Led the development and approval of multiple breakthrough medicines…

PortfolioAltamarCAM and Asabys agree to integrate Aliath, their life sciences unit, into Asabys

October 2, 2025

AltamarCAM and Asabys agree to integrate Aliath, their life sciences unit, into Asabys

READ THIS NEWS IN SPANISH The resulting team will manage over €400M in investments in biotechnology and medical technologies. Management of the Alta Life Sciences Spain I FCR fund will…

Recapiti
Mark